Digital Diagnostics provides diagnostic services for the detection of diabetic retinopathy and diabetic macular edema. Digital Diagnostics is enrolled in the Medicare Program to provide and bill for these services as an Independent Diagnostic Testing Facility (IDTF).
IDx-DR was the first fully autonomous AI in any specialty of medicine to be cleared by the U.S. Food and Drug Administration (FDA) to diagnose diabetic retinopathy and diabetic macular edema after rigorous FDA validation for safety and equity.
What is an IDTF?
An IDTF is a facility that provides diagnostic tests independent of either a physician’s office or a hospital.
To date, Digital Diagnostics is the only IDTF under the Medicare Program that provides diagnostic services for the detection of diabetic retinopathy and macular edema. Digital Diagnostic’s service provided by IDx-DR was designed to support the PCMH and practitioners who care for patients with diabetes. The diabetic eye exam is an important part of comprehensive diabetes management. The FDA determined that IDx-DR met the standards for “breakthrough device” designation in accordance with section 3051 of the 21st Century Cures Act.
As an IDTF, Digital Diagnostics adheres to the Medicare Independent Diagnostic Performance Standards. These standards (42 C.F.R section 410.33) can be found at the Centers for Medicare & Medicaid Services Website.
Please Meet Our Team!
Aaron Roller, MD
Dr. Aaron Roller joined the Digital Diagnostics team in 2021 as Medical Supervisor for the Austin diagnostic testing facility. He and his family have been in Austin, TX since 2012, where he pursues his passion as a retina subspecialist in private practice. His relationship with Digital Diagnostics dates back to his ophthalmology residency and retina subspecialty training at the University of Iowa from 2007-2012, where he trained under the close mentorship of Dr. Abramoff, the company founder and visionary for implementation of artificial intelligence into healthcare screening. Dr. Roller was involved in data collection and algorithm training during the early implementation of AI in the infancy of what was then known as IDx, which would grow into Digital Diagnostics in years ahead. He remembers being inspired by Dr. Abramoff’s vision and the potential for development of AI diagnostics, and he feels honored and fortunate to have the opportunity to reunite with and contribute again to the evolution of this paradigm-changing project. After years of caring for thousands of central Texas patients with severe vision loss from advanced diabetic retinopathy, Dr. Roller is passionate about the potential of artificial intelligence to reduce the burden of vision loss from diabetes and other preventable diseases.
Tiffany Smaby, COT
Certified Ophthalmic Technician
Tiffany has been working in the field of Ophthalmology for over 8 years and has achieved a multitude of certifications along the way. Having experience working in several subspecialties of Ophthalmology, Tiffany has acquired a great passion for helping patients achieve the best possible outcomes depending upon various diagnoses and treatment options through education and empathy. Tiffany also enjoys paying it forward as the Ophthalmic Assisting Instructor at Austin Community College which aims at preparing the next generation of Ophthalmic Technicians to be knowledgeable, caring and effective members of the allied health care profession. She takes great pride when a student experiences that moment of truly understanding difficult concepts and enjoys keeping up with students as they progress through their careers. When Tiffany is not working directly with patients or students, she is spending time with her family, camping, gardening or baking.
Digital Diagnostics Centralized IDTF Location:
North Capital of Texas Highway 3700 Ste 450-B
Austin, Texas 78746
Hours of Operation: 9-5 CST